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 There is evidence for a common genetic link between alcohol and nicotine dependence.  
Rodents selectively bred for high alcohol consumption/responsivity are also more likely to self-
administer nicotine than controls. 
Objectives 
 The experiments examined the systemic response to nicotine, the effects of nicotine within 
the drug reward pathway, and innate expression of nicotine related genes in a brain region 
regulating drug reward/self-administration in multiple lines of rats selectively bred for high and 
low alcohol consumption.   
Methods 
 The experiments examined the effects of peripheral administration of nicotine on locomotor 
activity, the effects of nicotine administered directly into the (posterior ventral tegmental area; 
pVTA) on dopamine (DA) release in the nucleus accumbens shell (AcbSh), and innate mRNA 
levels of acetylcholine receptor genes in the pVTA were determined in 6 selectively bred 
high/low alcohol consuming rat lines with Wistar as controls. 
Results 
 The high alcohol-consuming rat lines had greater nicotine-induced locomotor activity 
compared to low alcohol-consuming rat lines.  Microinjections of nicotine into the pVTA resulted 
in DA release in the AcbSh with the dose response curves for high alcohol-consuming rats 
shifted leftward and upward.  Genetic analysis of the pVTA indicated differences in nicotinic 
receptors (α2 and β4).   
Conclusion 
 Selective breeding for high alcohol preference resulted in a genetically divergent behavioral 
and neurobiological sensitivity to nicotine.  The observed behavioral and neurochemical 
differences between the rat lines would predict an increased likelihood of nicotine reinforcement.  
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The data support the hypothesis of a common genetic basis for drug addiction and identifies 
potential receptor targets. 
Deehan 4 
Introduction 
The brain reward system regulates numerous motivationally relevant behaviors in an 
effort to attain natural rewards (i.e, food, sex, etc.).  Drugs of abuse exert their effects within the 
brain reward system, exploiting natural processes, thereby increasing the propensity to 
consume drugs in the future.  There is a strong genetic component determining the 
characteristics of the brain reward system (Hall et al., 2014; Parsons & Hurd, 2015). It is this 
genetically mediated development of the reward system that has lead researchers to suggest a 
common genetic predisposition to develop an addictive disorder (Grant et al., 2011; Uhl, 2004; 
Uhl et al., 2008a; 2008b).  For instance, a family history of alcoholism predisposes individuals to 
exhibit eating, gambling and sexual disorders as well as an increased risk of alcoholism and 
addiction to other drugs of abuse (Grant et al., 2011; Kamarajan et al., 2015).  The St. Louis 
Epidemiological Catchment Area (ECA) longitudinal study has clearly indicated that the highest 
rate of comorbidity observed was between gambling, alcohol use disorders and antisocial 
personality disorders (Cunningham-Williams et al., 1998).  Thus, epidemiological evidence 
suggests that a genetic predisposition to develop alcoholism is associated with an altered 
natural brain reward system. 
The two most common co-abused drugs are alcohol and nicotine. Individuals that are 
nicotine dependent (ND) are 10 times more likely to be diagnosed with alcoholism than non-
smokers in their lifetime (DiFranza & Guerrera, 1990). In ND individuals, the rate of concurrent 
alcohol dependency (AD) is between 2.7 and 4.4 times higher than in non-smokers (Breslau, 
1995; Grant et al., 2004).  Preclinical data also indicate there is a possible genetic association 
between ethanol (EtOH) and nicotine (NIC) sensitivity.  The alcohol-preferring (P) rat self-
administered (i.v.) NIC at 4-fold lower concentrations than non-alcohol preferring (NP) rat, and 
self-administered approximately 3-4 fold more NIC than NP rats, and expressed greater drug-
elicited (NIC primed) NIC seeking than NP rats (Le et al., 2006).  The posterior ventral 
tegmental area (pVTA) is a neuroanatomical site supporting the reinforcing properties of EtOH 
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(Rodd et al., 2005; Rodd-Henricks et al., 2000) and NIC (Ikemoto et al., 2006; Hauser et al., 
2014).  Rats will readily self-administer EtOH or NIC directly into the pVTA (Rodd-Henricks et 
al., 2000; Rodd et al., 2005; Ikemoto et al., 2006; Hauser et al., 2014; Rodd et al., 2004a) and 
the pVTA of P rats is more sensitive (requires a lower concentration of NIC to establish self-
administration behaviors) to the reinforcing properties of NIC (Rodd et al., 2004a) than Wistar 
rats.  Thus, the data suggest that selective breeding for high-EtOH preference results in a 
genetic phenotype that also possesses increased sensitivity to the rewarding effects of NIC 
which is, in part, mediated by the pVTA DA system.   
The current experiment utilized 6 selectively bred rat lines to determine if a genetic 
predisposition for high alcohol preference, and intake, is associated with an alteration in 
response to systemic NIC (locomotor activity: LMA), the neurochemical response to NIC 
microinjected directly into the brain reward pathway, and innate expression of the acetylcholine 
receptor genes within the pVTA.  Psychostimulant-induced LMA has been hypothesized as 
indicating the incentive motivational processes of these drugs (Pert et al., 1990).  The 
development of LMA sensitization is thought to be indicative of neuroadaptations within the 
mesolimbic dopamine system that increases the likelihood to self-administer drugs and to 
develop dependence/addiction to these compounds (Thomas et al., 2008).  It was hypothesized 
that rats selectively bred to prefer/consume alcohol would exhibit a greater LMA and 
neurochemical (extracellular dopamine) response in the nucleus accumbens shell (AcbSh) 
following microinjections of NIC into the pVTA than non-consuming or Wistar rats.  Further, it 
was hypothesized that selective breeding for alcohol preference/intake alters the expression of 
acetylcholine receptor genes within the pVTA. 
Materials and Methods 
Subjects  
 Experiments utilized the alcohol-preferring (P) and non-preferring (NP) rat lines, Wistar rats, 
and both the High- (HAD) and Low-alcohol drinking (LAD) rat lines.  All animal care was in 
Deehan 6 
accordance with the Guidelines for the Care and Use of Laboratory Animals (RIFLA, 2011) and 
experiments were approved by the Indiana University School of Medicine IACUC committee.   
Nicotine 
 NIC hydrogen tartrate (Sigma-Aldrich, St. Louis, MO) was dissolved in 0.9% sterile saline 
(Exp 1) or artificial cerebral spinal fluid (aCSF; Exp 2). All doses/concentrations of NIC used is 
based upon salt, not free base. All solutions were pH adjusted to 7.3. 
Experiment 1: Effects of NIC on LMA in Selectively Bred Rat Lines 
 Motor activity was assessed in arenas previously described (Bracken et al., 2011). 
NIC induced locomotor activity in P and NP Rats 
 Adult male P and NP rats were tested during 2 hr sessions.  After the 1st hr (daily habituation 
period), rats were removed from the activity monitors and injected (s.c., 1 mg/ml) with 0, 0.25, or 
0.5 mg/kg (n = 8/group/line) NIC and then immediately placed back into the activity monitor.  
The doses used are from the literature and readily establish NIC-induced LMA in outbred rats 
following repeated injections (Bracken et al., 2011, Berg & Chambers, 2008).  Activity from the 
2nd hr was used to determine the effects of drug administration over 7 consecutive daily activity 
sessions.  Two weeks after completing the injection series, all rats received a NIC challenge 
injection (0.5 mg/kg).  P and NP rats are derived from an extinct stock of Wistar rats (c.f. Bell et 
al., 2016).  Originally, the experiment was designed to include Harlan Wistar (Indianapolis IN) 
rats as a neutral control.   During the time period of data collection, Harlan Wistar rats were not 
available (Parvo outbreak).  Charles River Wistar (Wilmington MA) rats were purchased but 
were deemed to be sufficiently different from Harlan rats and not to be suitable for use.  In our 
hands, the Charles River Wistar subjects never habituated to the injection procedure, displayed 
freezing behaviors during LMA testing (no injection given prior to freezing), and express a 
bimodal distribution for LMA (half very little activity, the other half displayed modest activity).  
Therefore, comparisons between P/NP and Wistar rats will rely on the established literature. 
Nicotine induced locomotor activity in HAD and LAD Rats 
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 Adult female HAD-1 (n = 28), HAD-2 (n = 23), LAD-1 (n = 16) and LAD-2 (n = 22) were 
tested during 2 hr sessions (identical to P/NP study).  Rats were given 10 activity sessions.  The 
additional 3 days of NIC exposure was given because of the possibility that the LAD lines would 
display sensitization to NIC-induced LMA with additional sessions.  Activity sessions were 
conducted Monday-Friday for two consecutive weeks with a NIC challenge injection (0.5 mg/kg) 
2 weeks later.  Females were used for two reasons.  First, it was desired to extend the male 
findings in the P/NP study to the opposite sex and because of availability.  The HAD and LAD 
rats lines are maintained at low numbers, and HAD male rats are dedicated for a medication 
development contract. 
Statistical Analysis 
 Data from day one of the injection series and the final challenge session were examined 
using a two-way ANOVA with independent factors of line and drug condition on the dependent 
measure of activity.  The initial injection series was examined using a repeated measure 
ANOVA with days as the within subject measure.  Post-hoc comparisons were made using the 
Tukey’s b analysis.  
Experiment 2:  Effects of NIC microinfusions in the VTA on DA Efflux in the AcbSh 
 Detailed methodology can be obtained from previous publications (Deehan et al., 2013; 
Deehan et al., 2015).  Naïve adult female P, Wistar, HAD-1, HAD-2, LAD-1 and LAD-2 (n = 7-
9/line/ location/concentration) rats were used in this experiment.  NP rats bleed excessively 
during surgeries which preclude NP rats from being used in experiments involving surgery.  
Instead, Wistar rats were used as a comparison for P rats.  Wistar rats have been used 
previously for comparisons with P rats (Hauser et al., 2014; Rodd et al., 2004a; 2004b).  In total, 
269 rats were used in this experiment; 146 rats had placements within the pVTA and 123 rats 
had placements within the anterior VTA (Paxinos & Watson, 2005).  The connections between 
the dorsal raphe and the VTA display a heterogeneous pattern.  The transtegemental serotonin 
pathway, which originates in the DR and median raphe nuclei primarily innervate dopaminergic 
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and non-dopaminergic cells in the interfascicular nucleus (IF) and posterior VTA with little 
indication of innervation in the anterior VTA (Herve et al., 1987).  We defined the pVTA as the 
portion of the VTA that serotonin innervation (IF present) which occurs between -5.4 and -6.2 
mm bregma.  The anterior VTA was defined are the region of the VTA which occurs between -
4.8 and -5.2 bregma. 
 The data collected in this experiment required >3200 hours of work and the costs exceeded 
$200,000 (US$).  Males were not conducted in this portion of the experiment because of cost 
and work demands. 
Microinjection/Microdialysis Procedure 
 The general procedures have been previously described (Deehan et al., 2013).  Four to five 
20-min baseline samples were collected prior to the start of microinjections.  Microinjections 
were administered at a volume of 100 nl over a 5-sec period 3 times a minute (every 20 sec) 
during the first 10 min of the sample (30 microinjections total).  This injection protocol mirrored 
self-administration for NIC into the pVTA (Hauser et al., 2014).  Following microinjections, a 
minimum of 5 additional samples were collected.  All lines were microinjected with aCSF, 10 or 
100 µM NIC with additional groups of P and Wistar rats receiving 200 µM NIC.  
Sample Analysis 
 Samples were analyzed for DA content using a reversed-phase high pressure liquid 
chromatography (HPLC) system as previously described (Engleman et al., 2006).   
Statistical Analysis 
 The data are presented as a percent of baseline (average of final 3 baseline samples) value.  
Initial analysis consisted of a Rat line x Drug Concentration x Sample mixed analyses of 
variance (ANOVA).  When significant effects (p<0.05) were observed using the mixed 
ANOVA’s, post hoc Tukey’s b or Student’s t-tests were utilized to determine differences 
between specific drug concentrations and across the time course of sample collection.   
Experiment 3:  Innate mRNA Levels in the pVTA of all Rat Lines 
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 Subjects were naïve male P, NP, Wistar, HAD-1, HAD-2, LAD-1, and LAD-2 rats (n = 8/line).  
Tissue Preparation and Micropunch for RT-PCR  
All equipment and working surfaces were kept RNase free during dissection of the 
regions of interest. Frozen brains were sliced at 300 μm (coronal), using a Leica cryostat, and 
slices were placed onto microscope slides. The pVTA was dissected out of seven adjacent 300 
μm coronal brain slices (from approximately -5.5 to -6.0 mm from bregma; Paxinos and Watson, 
2005) using a 1.0-mm Harris Micro-punch (Electron Microscopy Sciences, Hatfeild, PA). The 
pVTA tissue was immediately placed into 75 μl of SurePrepTM TrueTotalTM RNA purification 
buffer (Fisher Scientific), and samples were vortexed and frozen on dry ice and kept at −80 °C 
overnight. 
RNA was isolated using SurePrepTM TrueTotalTM RNA Purification Kit (Fisher 
Scientific). Total RNA was determined using Nanodrop 1000. Extracted RNA was then reverse 
transcribed using the GeneAmp Gold RNA PCR kit (Applied Biosystems) at the following 
reaction conditions: 2.5 μM Oligo-dT primer, 2.5 mM magnesium, 250 mM of each 
deoxynucleotide triphosphate, 0.5 U/ml of RNase inhibitor, and final concentration of 0.75 U/μl 
of MuLV reverse transcriptase. The reverse transcription conditions were 10 min at room 
temperature, 15 min at 42 °C, 10 min at 68 °C, and 5 min at 95 °C and produced approximately 
25 μl of product. 
 The TaqMan® Low-Density Arrays (TMLDA) is a multiple rtPCR assay that quantifiably 
examines mRNA levels.  We have previously used the TMLDA assay to assess the effects of 
EtOH and NIC microinjected into the pVTA on gene expression in the AcbSh (Truitt et al., 
2015). The current TMLDA (Applied Biosystems) was an 18 acetylcholine gene array.  The 
following acetylcholine related genes were assayed; Ache, Cdnf, Chat, Chrm1, Chrm2, Chrm3, 
Chrm4, Chrm5, Chrna2, Chrna3, Chrna4, Chrna5, Chrna6, Chrna7, Chrnb1, Chrnb2, Chrnb3, 
and Chrnb4.  All subjects were adult males. 
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A cDNA sample (100 μl) isolated from the pVTA from each rat was added to an 
equal volume of TaqMan® universal PCR master mix (Applied Biosystems). After gentle mixing 
and centrifugation, the mixture was transferred to a loading port on a TMLDA card. The array 
was centrifuged twice for 1 min, each at 1,200 rpm, to distribute the samples from the loading 
port to each well. The card was then sealed and PCR amplification performed using an Applied 
Biosystems Prism 7900HT sequence detection system (equipped with a TaqMan® low-density 
array upgrade). Thermal cycler conditions were as follows: 2 min at 50 °C, 10 min at 94.5 °C, 
30 s at 97 °C, and 1 min at 59.7 °C for 40 cycles. A common threshold was set for all genes 
using RQ manager software (ABI). The Ct values obtained from the RQ manager (ABI) were 
then imported into RealTime StatMiner v4.5 (Integromics) for further analyses. 
Reference gene selection. The TMLDAs included 18S, glyceraldehyde 3-phosphate 
dehydrogenase (Gapdh), hypoxanthine phosphoribosyltransferase 1 (Hprt1), ribosomal protein, 
large, P2 (Rplp2), and ubiquitin C (Ubc) as reference genes based on their proven role as 
housekeeping genes and their uniform expression in preliminary TMLDA rat endogenous control 
assays from rat pVTA(data not shown). The geNORM procedure, also known as the pairwise 
approach, included in the RealTime StatMiner (Integromics) software was utilized to determine 
the stability of the selected reference genes, as described previously (Vandesompele et al. 
2002). Using this approach, the following genes were selected for normalization of gene 
expression levels: Gapdh, Hprt1, and Ubc. 
 
Results 
Experiment 1: Effects of NIC on LMA in Selectively Bred Rat Lines 
Initial response to NIC 
Methodological (male/female rats and the number of nicotine exposure days 7 vs 10) 
and behavioral (P/NP were more active than HAD/LAD rats) differences precluded performing 
an overall analysis on locomotor activity.  In P and NP rats (data not shown) the analysis 
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revealed a Dose x Line interaction (F2, 42 = 3.53; p = 0.038).  Analyses revealed a significant 
effect of Dose in P (F2,21 = 4.36; p = 0.026) and NP (F2,21 = 4.73; p = 0.02) rats.  Specifically, 
LMA was increased in P rats administered 0.5 mg/kg NIC compared to saline, whereas LMA 
was decreased in NP rats administered 0.25 or 0.5 mg/kg NIC.  Analysis of the HAD/LAD data 
following an initial injection of NIC (data not shown) revealed a significant Line x Dose 
interaction (F6,77 = 4.0; p = 0.002).  For HAD-1 and HAD-2 rats, injection of 0.5 mg/kg NIC 
increased LMA compared to saline and 0.25 mg/kg NIC groups (F values > 17.49; p values < 
0.0001).  There was no effect of NIC administration on the LMA of LAD-1 (F2,13 = 0.04; p = 0.96) 
or LAD 2 rats  (F2,19 = 3.37; p = 0.07).   
Response to repeated NIC injections 
Repeated injections of NIC (Fig. 1) in P and NP rats produced a significant Day x Line x 
Dose interaction (F12,76 = 2.0; p = 0.031).  P rats repeatedly treated with 0.5 mg/kg exhibited a 
significant increase in LMA across the days (F6,2 = 8.73; p = 0.029; specifically during the 4th 
and 7th days compared to the 1st day (t7 values > 3.0; p values < 0.019).  In contrast, there were 
no effects of repeated NIC administration on LMA in the NP rats  
Similar to the P/NP study, the overall analysis in HAD/LAD rats indicated a significant 
Day x Line X Dose interaction (F 54, 1284 = 1.87; p < 0.001).  Repeated injections of NIC (Fig. 2) 
produced a significant effect of Line on LMA for rats injected with 0.5 mg/kg NIC (F3,28 = 3.77; p 
= 0.022) as the HAD-1 and HAD-2 lines expressed greater 0.5 mg/kg NIC-induced LMA than 
LAD-1 rats.  More specifically, for HAD-1 rats, 0.5 mg/kg NIC increased LMA compared to 
saline and 0.25 mg/kg NIC for all 10 sessions.  For HAD-2 rats, repeated injections of 0.25 
mg/kg significantly increased LMA during days 8-10 compared to day 1 as well as days 9 and 
10 compared to day 2 (p values < 0.023).  Additionally, injections of 0.5 mg/kg significantly 
increased LMA during days 8-10 compared to days 1 and 2 (p values < 0.037).  In LAD-2 rats, 
repeated injections of saline produced a decrease in LMA (habituation) between sessions 1-3 
compared to sessions 8-10 (t > 5.4; p values < 0.003).  However, 0.5 mg/kg NIC increased LMA 
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between the initial sessions compared to the last sessions (t values > 2.9; p values < 0.024) 
whereas 0.25 mg/kg NIC failed to alter LMA (p values > 0.09).  Repeated injections of saline, 
0.25 or 0.5 mg/kg NIC failed to dose dependently alter LMA in LAD-1 rats.   
Analysis across lines for animals receiving 0.5 mg/kg NIC yielded a significant effect of 
Line for all 10 Days (F3,28 values > 3.5, p values < 0.028).  Post-hoc comparisons indicated that 
HAD-2 rats displayed significantly more LMA following injections of 0.5 mg/kg NIC than LAD-1 
and LAD-2 rats across all 10 days.  HAD-1 rats displayed significantly more LMA than LAD-1 
rats for all 10 days and LAD-2 rats for 7 out of 10 days. There was no significant effect of Line in 
rats injected with 0.25 mg/kg for the 10 days (p values > 0.08).  In rats injected with saline there 
was a significant effect of Line during days 3 and 5 (p values < 0.001), an effect driven by 
greater LMA in LAD-1 rats during those days. 
Response to challenge injection of NIC 
The challenge dose (0.5 mg/kg) of NIC administered 14 days after the last treatment 
session produced a significant Dose x Line interaction (F2, 42 = 4.36; p < 0.0001) in P/NP rats 
(Fig. 3; top panel).   Basically, LMA in NP was still reduced following exposure to the NIC 
challenge dose, and the NIC challenge dose resulted in an increase in LMA in P rats with a 
previous history of exposure to 0.5 mg/kg NIC.  In the HAD/LAD rats (Fig. 3; bottom panel), 
there was a significant Dose X Line interaction (F6,77 = 2.28; p = 0.045).  Post-hoc comparisons 
indicated that HAD-1 and HAD-2 rats displayed significantly greater LMA during the challenge 
day than LAD-1 and LAD-2 rats.  There was no significant effect of Line on LMA during the 
challenge day for rats previously injected with saline or 0.25 mg/kg.  LAD-2 rats previously 
administered 0.25 or 0.5 mg/kg NIC displayed more LMA during the challenge day than saline 
controls.  In contrast, there was no significant effect of previous Drug History on LMA during the 
challenge test in LAD-1 rats (F2,13 = 1.17; p = 0.34). 
Experiment 2:  Effects of NIC microinfusions in the VTA on DA Efflux in the AcbSh  
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Extracellular basal dopamine estimates in the AcbSh for each rat line were as follows: P 
– 1.36 + 0.15, Wistar – 1.23 + 0.13, HAD-1 – 1.06 + 0.24, HAD-2 – 0.99 + 0.27, LAD-1 – 1.13 + 
0.20, and LAD-2 – 1.05 + 0.22 µM.  Probe recovery heavily influences estimated basal levels 
under standard microdialysis procedures (accurate basal levels can only be assessed utilizing a 
No-Net-Flux protocol).  
The overall analysis (all 6 lines; Figs. 4 & 5) indicated a significant Time x Line x 
Location x NIC concentration interaction (F90,1854 = 1.35; p = 0.018). Analyses in which location 
was held constant revealed that there was a significant Time x Line x NIC concentration (F90,1854 
= 2.83; p < 0.0001) in rats with cannula placements in the pVTA, but no significant effects for 
rats with placements in the aVTA (p values > 0.26; data not shown).  To reduce redundancy in 
statistical analysis, the significant 3-way interaction term has been decomposed into an 
examination between high alcohol drinking rat line and the corresponding low alcohol drinking 
parallel line. 
P vs Wistar Analysis 
 For the P line, there was a significant Time x NIC concentration interaction (F27,63 = 2.34; p = 
0.003; Fig. 4).  Individual ANOVAs revealed a significant effect of NIC concentration during the 
1st – 3rd sample period following microinjection (F3,27 values > 5.0; p values < 0.007). During the 
1st and 2nd sample following NIC microinjection DA levels in the AcbSh were higher in P rats 
administered 10 and 100 µM NIC compared to the aCSF.  Additionally, during the 1st – 3rd 
sample following administration of 200 µM NIC in P rats, DA levels in the AcbSh were 
significantly greater than all other groups.  Wistar rats also exhibited a significant Time x NIC 
concentration interaction (F27,63 = 3.14; p < 0.001). Analyses revealed a significant effect of NIC 
concentration during the 1st and 2nd post-injection samples (F3,27 values > 7.159; p values < 
0.001). Specifically, during the 1st post-injection sample, 100 µM NIC produced significantly 
higher DA efflux than aCSF.  Animals receiving 200 µM NIC exhibited significantly higher DA 
levels than aCSF and 10 µM groups during the 1st and 2nd post-injection samples (p < 0.05).  
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Between line comparisons (P vs Wistar) yielded significant elevations in DA release for P rats 
administered 10 µM NIC during the 1st post-injection sample (F1,13 = 4.78; p = 0.041).  
Microinjections of 200 µM NIC, elevated DA extracellular levels during the 1st – 3rd post-injection 
samples (F1,13 values > 4.95; p = 0.037) compared to the Wistar groups.  
HAD-1 vs LAD-1 Analysis 
For HAD-1 rats (Fig. 5), there was a significant Time x NIC concentration interaction 
term (F18,24 = 2.1; p = 0.041).  Analyses revealed a significant increase in extracellular DA levels 
within the AcbSh during the 1st and 2nd post-injection samples (F2,19 values > 4.855; p values < 
0.02). Post-hoc comparisons revealed that, for the 1st post-injection sample, DA levels in the 
AcbSh of the groups were significantly different from each other. During the 2nd post-injection 
sample, 100 µM NIC significantly elevated DA levels compared to the aCSF group. Between 
line comparison (HAD-1 vs LAD-1) yielded significant elevations in DA levels for HAD-1 rats 
following microinjections of 10 or 100 µM NIC during the 1st post-injection sample (p values < 
0.004) and following microinjections of 100 µM NIC during the 2nd post-injection sample (p < 
0.001) compared to their LAD-1 counterparts. 
HAD-2 vs LAD-2 Analysis 
 For HAD-2 rats (Fig. 5) there was also a significant Time x NIC concentration 
interaction (F18,24 = 2.14; p = 0.041).  Individual ANOVAs indicated that there was a significant 
effect of NIC concentration administered on extracellular DA levels in the AcbSh in HAD-2 rats 
during the 1st and 2nd time period following microinjections (F2,19 values > 4.91; p values < 
0.019). Post-hoc comparisons indicated that during these two time periods all groups (aCSF, 10 
and 100 µM NIC) were statistically different from each other.  Unlike the LAD-1 rats, LAD-2 rats 
displayed a significant Time x NIC concentration interaction (F18,18 = 2.77; p = 0.023). Follow-up 
analyses determined there was a significant effect of NIC concentration administered on DA 
levels in the AcbSh in LAD-2 rats during the 1st and 2nd time periods following microinjections 
(F2,17 values > 8.59; p values < 0.003). Post-hoc comparisons indicated that during these two 
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time periods the 100 µM NIC group was statistically different from the aCSF and 10 µM NIC 
groups.  Between line comparisons (HAD-2 and LAD-2) yielded significant elevations in DA 
levels in for HAD-2 rats 10 or 100 µM NIC during the 1st post-injection sample (p values < 0.007) 
and following microinjections of 100 µM NIC during the 2nd post-injection sample (p < 0.019) 
compared to their LAD-2 counterparts. 
Area under the Curve Analysis – All Rat Lines 
  A standard Area under the Curve (AUC) analysis was performed in all rats (6 lines) 
microinjected with 100 µM NIC directly into the pVTA with linear value derived from extracellular 
DA levels in the AcbSh (data not shown).  The AUC analysis (y = f(x)) is an x-axis functional 
analysis that provides a definite integral of a value across a certain independent variable (e.g., 
time) in which the trapezoidal rule is applied to obtain a quantitative value (AUC).  An ANOVA 
indicated a significant effect of Line (F5,46 = 36.8; p < 0.0001).  Post-hoc comparisons (Tukey’s 
b) indicated that P, HAD-1, and HAD-2 were significantly higher than Wistar, LAD-1, and LAD-2 
(no other differences). 
Experiment 3:  Innate mRNA Levels in the pVTA of all Rat Lines 
P – Wistar- NP Comparison 
 All TMLDA data were normalized to a log10 base for analysis (Fig. 6 and Table 1).  
Statistically, there was a significant effect of rat line for the expression of the muscarinic 4 
receptor (F2, 15 = 8.97; p = 0.03) and the α2, α3, α5, and β4 subunits of the nicotinic receptor (F2, 
15 values > 13.29; p values = 0.0.0001, 0.002, 0.007, 0.0001, respectively).  Post-hoc 
comparisons (SNK) indicated that expression of chrm4 was significantly reduced in the NP rats 
(different from all other groups).  There were two genes in which expression was reduced in 
both the P and NP rat lines compared to the Wistar controls (chrna3 and chrna5).  Of particular 
interest were the two nicotinic receptor subunits that were divergently expressed (P rat 
increased, NP rats decreased) compared to the Wistar rats, and each other (chrna2 and chrb4). 
HAD-LAD Comparison 
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 Statistically, there was a significant effect of rat line for the expression of the muscarinic 2 
receptor and the α3 and α7 receptor subunit of the nicotinic receptor (F3, 22 values > 13.3; p 
values = 0.0001, 0.002, and  0.01, respectively; Fig. 7 and Table 2).  Post-hoc comparisons 
(SNK) indicated that the expression of the chrm2 was significantly reduced in the HAD-1 rats 
compared to all other rats.  The HAD-2 rat lines had a significant reduction in the expression of 
the chrna3 compared to the other rat lines.  Expression of the chrna7 receptor subunit was 
increased in both HAD-1 and HAD-2 rat lines compared to both the LAD-1 and LAD-2 rat lines. 
Discussion 
High alcohol-consuming rat lines were more responsive to nicotine than the low alcohol-
consuming rat lines or unselected Wistar rats.  The pleiotropic association between genetic 
predisposition to consume/prefer ethanol and enhanced responsiveness to the effects of 
nicotine was evident during systemic assessment (Figs. 1-3) and in specific neuroanatomical 
sites mediating drug reward (Figs. 4-5; for full summary see Table 3).  Specifically, acute 
nicotine increased LMA in all 3 selectively bred rat lines compared to the low alcohol-consuming 
lines.  Utilizing an identical experimental protocol, Wistar rats required 6, while Sprague-Dawley 
rats required 5, daily injections to observe a NIC-induce increase in LMA (Bracken et al., 2011, 
Berg & Chambers, 2008). In other experimental protocols, unselected rat lines do not express 
an NIC-induced LMA following the initial exposure to NIC (Bracken et al., 2011, Berg & 
Chambers, 2008).  P and HAD-2 rats rapidly develop sensitization to NIC-induced LMA (day 4 
and 7).  Thus, in outbred rats, NIC sensitization is the expression of NIC-induced LMA, while in 
the P and HAD rats NIC sensitization is a significant increase to an already established 
behavior.  These two observations could be different effects.  A limitation in this assertion is that 
male rats were used for the P/NP comparison while female rats were used for the HAD/LAD 
component. 
The data clearly indicate that selective breeding for high alcohol preference has resulted 
in an innate reward system that is more responsive to NIC (Figs. 4-5).  The pVTA supports the 
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self-administration of ethanol and/or NIC (Rodd-Henricks et al., 2000, Rodd et al., 2004a, Truitt 
et al., 2015).  Previous data have indicated that P rats self-administer NIC at lower 
concentrations and at a higher rate than Wistar rats into the pVTA (Hauser et al., 2014).  
Convergently, extracellular DA levels in the P rats are increased by microinjections of 10 µM 
NIC in the pVTA compared to Wistar rats (Fig. 4).  The data suggest that the willingness of P 
rats to self-administer lower concentrations of NIC into the pVTA may be based upon a 
corresponding increase in DA in the AcbSh.  Similar data (Fig. 5) were observed in the HAD-
1/HAD-2 rat lines compared to their selective counterparts (LAD-1/LAD-2).  Of note, the anterior 
VTA does not support NIC self-administration (Ikemoto et al., 2006), and there is no alteration in 
extracellular DA levels in the AcbSh following NIC microinjected into this region (data not 
shown).   
The pleiotropic association between ethanol and NIC has been reported in other rodent 
models.  Mice selected for high EtOH-induced LMA are more sensitive to the locomotor 
stimulatory effects of morphine, cocaine, methamphetamine, and nicotine than mice selected for 
low EtOH-induced LMA (Bergstrom et al., 2003).  Furthermore, reverse selection of these mice 
indicated that there was a parallel loss in responsiveness to EtOH and other drugs of abuse 
(Bergstrom et al., 2003). Long-sleep mice are more sensitive than short-sleep mice to the 
actions of nicotine in several behavioral paradigms (De Fiebre et al., 1987).  This effect is also 
observed in rats (cross species effect) since long-sleep rats are more responsive to NIC 
compared to short-sleep rats (De Fiebre et al., 2002). Therefore, multiple lines of research 
indicate that a phenotypic trait associated with selective breeding for high responsiveness to 
EtOH results in a corresponding augmented response to NIC. 
Examining the innate expression of acetylcholine related genes in the pVTA between P, 
NP, and Wistar rats indicated potential biological basis for the divergent behavioral and 
neurochemical response between the rat lines (Fig. 6).  NP rats have a reduction in the 
expression of M4 AchRs.  Alterations in the M4 receptor have been linked to abnormal social 
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behaviors, altered prepulse inhibition, and a reduced cocaine-induced LMA (Koshimizu et al., 
2012; Stein & Hell, 2010).  Acute NIC-induced LMA sedation may be related to M4 expression.  
The chrna2 gene was divergently expressed in the P (increased) and NP (decreased) rat lines 
compared to Wistar controls.  The α2 nAchR has been associated with alcohol dependence and 
the much broader antisocial drug dependence in adolescence (Corley et al., 2008).  Increased 
expression of chrna2 is linked with heavy cigarette use (Cannon et al., 2014). The α5, α3, β4 
receptor subunits are clustered on the same chromosome and have been linked with amount of 
daily NIC use (Furberg et al., 2010).  In addition, genetic expression of the CHRNA5/A3/B4 
cluster is linked to various nicotine phenotypes including likelihood to relapse and craving 
(Shmulewitz et al., 2016; Ware et al., 2011) and (in particular variants of the β4 receptor) 
associated with a genetic predisposition to alcoholism (Hallfors et al., 2013).  Alterations in the 
α5, α3, β4 receptor subunits have been shown to modify the response of VTA DA neurons to 
drugs of abuse (Morel et al., 2014), which could be the biological basis for the neurochemical 
response difference between P and Wistar rats. 
Contrasting the innate expression of acetylcholine related genes between HAD-1, HAD-
2, LAD-1, and LAD-2 rats revealed significant differences (Fig. 7).  HAD-1 rats had significantly 
lower expression of the M2 acetylcholine receptor than all other groups.  The M2 receptor is 
associated with an increased risk of substance disorders, major depressive disorder, and 
college binge drinking (Bauer & Ceballos, 2014).  Only P and HAD-2 rats had a reduction in the 
genetic expression of the α3 subunit in the pVTA (HAD-1 did not).  The α3 subunit mediates the 
development of sensitization to NIC-induced and EtOH-induced LMA (Kamens et al., 2009).  
Only P and HAD-2 rats expressed the development of sensitization to NIC-induced LMA (Figs. 2 
and 3).  Therefore, in rats predispose to consume high amounts of alcohol, a reduction in the 
expression of the α3 subunit in the pVTA is correlated with a propensity to develop sensitization 
to NIC-induced LMA.  Enthusiasm for the α3 subunit finding is reduced because the NP rat line 
(no evidence of NIC-induced LMA) had the largest significant reduction in expression (Fig. 6). 
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Both HAD-1 and HAD-2 rats had increased expression of the α7 receptor subunit in the 
pVTA. The α7 receptors are located presynaptically on glutamate neurons that innervate DA 
neurons in the pVTA (Mansvelder et al., 2002) which may have contributed to the observed 
increase in dopaminergic response to NIC.  Yet, the increase in α7 receptor subunit was not 
observed in P rats (Table 1).  Recent unpublished work from our laboratory (Knight et al) has 
indicated that microinjection of an α7 receptor subunit into the pVTA stimulates DA release in 
the AcbSh.  Therefore, it is possible that increase in sensitivity and response to NIC in the HAD-
1 and HAD-2 rats may be linked to this receptor.  Overall, the PCR data sets indicate similarities 
between all selectively bred high alcohol consuming rats (selective enhancement in expression 
of nicotine receptors compared to control rats), but lack a single consistent target for the 
behavioral and biochemical effects.  These findings could be predicated upon the rat lines being 
derived from different founding stock (Wistars – P/NP, NIH HGS – HAD/LAD) and from the 
genetic pressure from selection.  It is possible that selective breeding for high alcohol 
consumption predispose an ‘enhance’ response to NIC compared to outbred stock of rats, and 
that selective breeding for low alcohol consumption has produced animals insensitive to NIC 
(NP and LAD-1 specifically).  This bidirectional effect of selection may be the cause of the 
muddled genetic findings.  It important to note that there was no single, consistent genetic factor 
in the pVTA in the rat lines selected for high alcohol consumption.  This could the result of 2 
factors; 1) there are multiple manners to alter a system that would have a similar behavioral 
effect and/or 2) given the limited number of genes assessed, the current study failed to examine 
the consistent genetic factor in all lines selectively bred for high alcohol consumption. 
Alterations within the reward pathway may predispose an individual to exhibit addictive 
disorder(s) toward natural rewards and drugs of abuse (Hall et al., 2014). The current 
experiments extend and verify the overall consensus in the literature that selective breeding for 
an alcohol phenotype produces animals with an enhanced response to NIC.  Recent meta-
analyses have indicated that the CHRNA5/A3/B4 and the α2 subunit are associated with this 
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common genetic predisposition to addiction (Buhler et al., 2015).  These critical genes were 
altered in the P rat compared to both Wistar and NP rats (β4 and α2).  Yet, it may not be 
specific genes but classes of genes that are more important, as the current results reflect this 
convergence of genetic selection on the nAchR system within the pVTA.  Therefore, it appears 
that genetic associated differences in, and/or drug-induced changes of the pVTA-nAChR 
system may provide molecular targets for pharmacogenetic medications screening/development 
to treat AD and/or ND. 
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Fig. 1 Displays the data for mean (+ SEMs) locomotor activity (LMA; cm traversed) by P and NP 
rats over the course of repeated (7 days) injections of 0.25, 0.5 mg/kg nicotine (NIC), or saline.  
* 0.5 mg/kg NIC injections in P rats caused significantly more LMA on days 4 and 7 compared to 
day 1 (p < 0.05).  Sample size - P (n = 8) and NP (n = 8) 
 
Fig. 2  Shows the data for mean (+ SEMs) locomotor activity (LMA; cm traversed) by HAD-1 
(upper left panel), LAD-1 (upper right panel), HAD-2 (lower left panel), and LAD-2 (lower right 
panel) rats during repeated (10 days) injections of saline, 0.25 mg/kg, or 0.5 mg/kg NIC.    
HAD-1: * 0.5 mg/kg NIC increased LMA in HAD-1 rats compared to LAD-1 and LAD-2 rats (p < 
0.05).  HAD-2:   * 0.5 mg/kg NIC significantly enhanced LMA in HAD-2 compared to LAD-1 and 
LAD-2 rats.  + repeated injections of 0.5 mg/kg NIC significantly increased LMA during sessions 
8-10 compared to sessions 1 and 2 (p < 0.037).  LAD-2:  # repeated saline injections caused a 
significant decrease in LMA during sessions 8-10 compared to sessions 1-3 (p < 0.003).  + 
repeated injections of 0.5 mg/kg NIC increased LMA in LAD-2 rats during sessions 8-10 
compared to sessions 1-3 (p < 0.024).  Sample size - HAD-1 (n = 28), HAD-2 (n = 23), LAD-1 (n 
= 16) and LAD-2 (n = 22).  
  
 
Fig. 3 Represents data for mean (+ SEMs) locomotor activity (LMA; cm traversed) by P and NP 
(top panel) and HAD-1,2  and LAD-1,2 (bottom panel) rats following a challenge injection of 0.5 
mg/kg NIC given approximately 14 days after repeated injections of 0.25, 0.5 mg/kg NIC or 
saline.  Top panel: * the challenge injection of 0.5 mg/kg NIC significantly elevated LMA in P 
rats compared to their NP counterparts (p < 0.001).  Bottom panel:  * challenge injection of NIC 
significantly elevated LMA compared to saline controls (p <  0.0001).  **  challenge injection of 
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0.5 mg/kg NIC significantly elevated LMA in HAD-1 and HAD-2 rats compared to LAD-1 and 
LAD-2 rats (p < 0.001).    
 
Fig. 4  Displays the mean (+ SEMs) extracellular levels of DA for P (top panel) and Wistar rats 
(bottom panel) in the nucleus accumbens shell (AcbSh) following pulse microinjections of aCSF, 
10 uM, 100 uM, or 200 uM NIC into the posterior ventral tegmental area (pVTA; n = 7-
9/line/concentration).  * indicates that in P rats DA levels are higher in the 10 and 100 µM Nic 
groups compared to baseline, and rats administered 200 µM Nic have higher DA levels than all 
other groups . + indicates that rats administered 200 µM Nic have higher DA levels than all 
other groups. # indicates that in Wistar rats administration of 100 µM Nic resulted in elevated 
DA compared to aCSF controls, and 200 µM Nic administered rats had higher DA levels 
compared to aCSF and 10 µM Nic rats. Δ indicates that increase in DA% in the AcbSh in P rats 
microinjected with 10 µM NIC into the pVTA was significantly greater than that observed with 
Wistar rats. σ indicates that increase in DA% in the AcbSh in P rats microinjected with 200 µM 
Nic into the pVTA was significantly greater than that observed with Wistar rats. 
 
Fig. 5  Displays the mean (+ SEMs) extracellular levels of DA for HAD (top two panels) and LAD 
rats (bottom two panels) in the nucleus accumbens shell (AcbSh) following microinjections of 
aCSF, 10 µM, or 100 µM NIC into the posterior ventral tegmental area (pVTA; n = 7-
9/line/concentration).  * indicates that all groups are different from each other (p’s < 0.02). + 
indicates that rats administered 100 µM Nic have higher DA levels than those receiving 10 µM 
NIC or aCSF (p’s < 0.019). Δ indicates that increase in DA% in the AcbSh in HAD-1 and HAD-2 
rats microinjected with 10 or 100 µM NIC into the pVTA was significantly greater than that 
observed LAD-1 or LAD-2 (corresponding with selective rat line) rats. σ indicates that increase 
in DA% in the AcbSh HAD-1 and HAD-2 rats microinjected with 100 µM NIC into the pVTA was 
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significantly greater than that observed LAD-1 or LAD-2 (corresponding with selective rat line) 
rats. 
 
Fig. 6  Displays the mean (+ SEMs) of the log10 transformation of the RT-PCR detection of 
acetylcholine related genes that were significantly different in P, NP, and Wistar (controls) rat 
lines in the posterior VTA using the TMLDA platform (n = 8/line).  * indicates significantly 
different from all other groups. # indicates that all groups are statistically different from each 
other.  + indicates that both the P and NP rats are statistically different from Wistar. 
 
Fig. 7 Displays the mean (+ SEMs) of the log10 transformation of the RT-PCR detection of 
acetylcholine related genes that were significantly different in HAD-1, LAD-1 (controls), HAD-2, 
and LAD-2 rat lines in the posterior VTA using the TMLDA platform (n = 8/line).  * indicates 
significantly different from all other groups.  + indicates that the HAD-1 and HAD-2 rats were 
significantly different from LAD-1 and LAD-2 rats. 
 
Table 1. Exhibits the gene change data (with SEM) for all genes measured within the pVTA of 
P, Wistar and NP rats.  All data is presented as fold-change compared to Wistar gene 
expression.  Sig indicates statistically significant results which are portrayed in Figure 8 (n = 
8/line). 
 
Table 2. Displays gene change data (with SEM) for all genes measured within the pVTA of both 
replicate lines of HAD and LAD rats.  All data is presented as fold-change compared to gene 
expression in the LAD-1 rat line. Sig indicates significant results which are portrayed in Figure 9 
(n = 8/line). 
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Table 3. Summarizes the significant changes to locomotor activity (Exp. 1) and DA efflux in the 
AcbSh (Exp. 2) between the different rat lines examined as well as the direction of change 
following NIC administration. Comparison groups are included.  For time course changes in DA 
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